CAS NO: | 1032823-75-8 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | GSK-1292263 is an orally availableGPR119agonist withpEC50s of 6.9 and 6.7 for human and ratGPR119, respectively. GSK-1292263 can be used for the research of type 2 diabetes mellitus (T2DM)[1]. | ||||||||||||||||
体内研究 (In Vivo) | GSK1292263 upregulates glucagon-like peptide-1 and enhances glucose-dependent insulin secretion and improves glucose homeostasis in type 2 diabetic rats[2].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 456.56 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C23H28N4O4S | ||||||||||||||||
CAS 号 | 1032823-75-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 20 mg/mL(43.81 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |